Follow-up of Cell Changes in the Cervix

NCT05709730 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 885

Last updated 2024-10-10

No results posted yet for this study

Summary

The purpose of the study is to follow up on cell changes detected in the cervical cancer screening program, to investigate whether they are handled with adequate quality.

Conditions

  • Cancer of Cervix

Interventions

DIAGNOSTIC_TEST

HPV genotyping

HPV genotyping of samples classified that were positive for "other HPV"

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Joakim Dillner, MD PhD · Joakim Dillner. Professor

Eligibility

Min Age
23 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-07
Primary Completion
2019-12-31
Completion
2029-12-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05709730 on ClinicalTrials.gov